Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.73 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetradecane SCHEMBL27634629 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Hexadecane SCHEMBL738410 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Heptane SCHEMBL27354631 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Trimethylammonium SCHEMBL18106783 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Octane SCHEMBL639577 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Pentadecane SCHEMBL27367365 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Dodecane SCHEMBL4314349 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Decane SCHEMBL28596369 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Octane SCHEMBL28596371 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Trimethylammonium SCHEMBL27943893 | 1.00 | TSHR (0.73) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106540660-B | For absorbing CO2The ionic liquid adsorbent material of gas and its application | 中国石油化工股份有限公司 | 2019-06-04 | — | — | CN | claimed |
| CN-106540660-A | For absorbing CO2The ionic liquid adsorbing material of gas and its application | 中国石油化工股份有限公司 | 2017-03-29 | — | — | CN | claimed |
| EP-2116242-B1 | NEW PHARMACEUTICAL COMPOSITION | SHENZHEN SALUBRIS PHARM CO LTD (CN) | 2016-10-12 | — | — | EP | claimed |
| CN-103751135-A | Zolmitriptan fast-release tablet and preparation method thereof | SHANGHAI TIANLONG PHARMACEUTICAL CO LTD | 2014-04-30 | — | — | CN | claimed |
| CN-103751128-A | Rapid-release fructose diphosphate sodium | SHANGHAI SANDY BIOPHARMACEUTICAL CO LTD | 2014-04-30 | — | — | CN | claimed |
| CN-103169678-A | Sulfadiazine rapid release tablet and preparation method thereof | SHANGHAI TIANLONG PHARMACEUTICAL CO LTD | 2013-06-26 | — | — | CN | claimed |
| CN-101616668-B | New pharmaceutical composition | ALLIST PHARMACEUTICALS INC | 2013-01-09 | — | — | CN | claimed |
| CN-102648918-A | New application of fructose diphosphate | SHANGHAI TIANLONG PHARMACEUTICAL CO LTD | 2012-08-29 | — | — | CN | claimed |
| US-8138214-B2 | Pharmaceutical composition | SHANGHAI ALLIST PHARMACEUTICAL, INC. (CN) | 2012-03-20 | — | — | US | claimed |
| CN-102114236-A | Biochemical oral liquid and preparation method thereof | SHANXI ZHENDONG PHARMACEUTICAL CO LTD | 2011-07-06 | — | — | CN | claimed |
| CN-1739504-A | L-ornidazole prepn | YANZIJIANG PHARMACEUTICAL INDU (CN) | 2006-03-01 | — | — | CN | claimed |
| CN-1732935-A | Compound orally administered formulation of Carvedilol and manidipine | HU CAIZHONG (CN) | 2006-02-15 | — | — | CN | claimed |
| CN-1732927-A | Orally administered formulation of mitiglinide calaium hydrate | HU CAIZHONG (CN) | 2006-02-15 | — | — | CN | claimed |
| CN-1689566-A | Compound carvedilol benidipine oral preparation | HU CAIZHONG (CN) | 2005-11-02 | — | — | CN | claimed |
| CN-1557311-A | Fibrauretine capsule tablet and its preparation method | 黄 羿 | 2004-12-29 | — | — | CN | claimed |
| CN-1457782-A | Dry spaxxacin suspension agent for resisting bacterial infection and its preparing method | HONGYI SCIENCE AND TECHNOLOGY (CN) | 2003-11-26 | — | — | CN | claimed |
| CN-1444940-A | Cresol powder with dissolution increased and its preparing method-analgesic, antipyretic and anti-inflammatory agent | HONGYI SCIENCE AND TECHNOLOGY (CN) | 2003-10-01 | — | — | CN | claimed |
| CN-1443535-A | Tegasevod maleate oral preparation and its preparation process-for curing intestinal irritability syndrome | NANCHANG HONGYI SCIENCE & TECH (CN) | 2003-09-24 | — | — | CN | claimed |
| CN-1439363-A | Dichloroacetic acid diisopropylamine oral preparation and its preparation process-treatment of liver function injury | HONGYI SCIENCE & TECHNOLOGY CO (CN) | 2003-09-03 | — | — | CN | claimed |
| CN-1439373-A | Oral preparation of mehanesulfonae pezusacine and its preparing process-antiinfection | HONGYI SCIENCE & TECHNOLOGY CO (CN) | 2003-09-03 | — | — | CN | claimed |